Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Follow us
Alexa global traffic share
Latest investments Show all
€34,000,000
Venture capital (Series B)
eTheRNA Immunotherapies
$4,500,000
Seed fund
DiogenX
Team Size
1–10
Employees
Location
Headquarters
Past year's investments
  • 4 rounds in the past year
  • $94.3M deployed in total
  • $23.6M avg per round
Latest rounds
  • eTheRNA Immunotherapies: Venture capital (Series B) (€34M)
  • DiogenX: Seed fund ($4.5M)
  • NBE-Therapeutics: Venture capital (Series C) ($22M)